|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-9-9
|
|
pubmed:abstractText |
Serum testosterone measurement has no widely accepted place in the management of patients with prostate cancer (PCa). However, several potential clinical applications of serum testosterone determination can be envisaged.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1873-7560
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
65-74
|
|
pubmed:dateRevised |
2011-4-29
|
|
pubmed:meshHeading |
pubmed-meshheading:20434831-Androgen Antagonists,
pubmed-meshheading:20434831-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20434831-Carcinoma,
pubmed-meshheading:20434831-Clinical Trials, Phase II as Topic,
pubmed-meshheading:20434831-Clinical Trials, Phase III as Topic,
pubmed-meshheading:20434831-Gonadotropin-Releasing Hormone,
pubmed-meshheading:20434831-Humans,
pubmed-meshheading:20434831-Male,
pubmed-meshheading:20434831-Orchiectomy,
pubmed-meshheading:20434831-Prognosis,
pubmed-meshheading:20434831-Prostate-Specific Antigen,
pubmed-meshheading:20434831-Prostatic Neoplasms,
pubmed-meshheading:20434831-Testosterone
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Testosterone measurement in patients with prostate cancer.
|
|
pubmed:affiliation |
Clinic E. Cavell and University of Brussels, Brussels, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Review
|
